Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ANNA M BURGNER

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1548464027
CMS profile
1175885
Location
NASHVILLE, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$6,000.00

4 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $6,000.00 4

By paying entity

PY2020 · entire year · sorted by reported total

Paying entityAmountRecords
Bayer HealthCare Pharmaceuticals Inc. $6,000.00 4

Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ANNA M BURGNER

NPI 1548464027 · CMS profile ID 1175885

Allopathic & Osteopathic Physicians / Internal Medicine / Nephrology

NASHVILLE, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1548464027?year=2020&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ANNA M BURGNER, NPI 1548464027, CMS profile ID 1175885. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1548464027?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). ANNA M BURGNER, NPI 1548464027, CMS profile ID 1175885. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1548464027?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
ANNA M BURGNER, NPI 1548464027, CMS profile ID 1175885, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1548464027?year=2020&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

4 matching records · $6,000.00 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 4 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–4 of 4.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Bayer HealthCare Pharmaceuticals Inc. $2,100.0010/25/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 713627403 CMS
Bayer HealthCare Pharmaceuticals Inc. $400.0009/28/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 713640837 CMS
Bayer HealthCare Pharmaceuticals Inc. $1,300.0008/02/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 713638005 CMS
Bayer HealthCare Pharmaceuticals Inc. $2,200.0005/31/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 713636729 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,650.00 1
PY2020 $6,000.00 4
PY2021 $3,300.00 2
PY2022 $12.14 1
PY2023 $21.56 7
PY2024 $3.08 1

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $75,332.97 12
PY2024 Principal investigator $127,714.36 15
PY2023 Principal investigator $158,582.97 14
PY2022 Principal investigator $60,395.17 5
PY2021 Principal investigator $86,492.21 31
PY2020 Principal investigator $101,388.33 48
PY2019 Principal investigator $167,148.86 86

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

86 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AstraZeneca Pharmaceuticals LP $592.46 12/31/2019 Non-covered Recipient Entity
Vanderbilt University Medical Center
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients with Chronic Kidney Disease No dispute reported 06/30/2026 684996111
Principal investigator 1 AstraZeneca Pharmaceuticals LP $181.96 12/31/2019 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients with Chronic Kidney Disease No dispute reported 06/30/2026 685004719
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $100.00 12/12/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629159697
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $500.00 12/12/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629172775
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,585.16 12/12/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629173871
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $750.00 12/12/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629176645
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,162.46 12/12/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629179681
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $5,284.00 11/13/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629174707
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $4,978.00 11/13/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629176831
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,007.00 11/07/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629174081
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $24,738.00 10/22/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629179391
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,644.00 10/09/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629161281
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,644.00 10/09/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629162845
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,256.00 10/09/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629170669
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,256.00 10/09/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629175891
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,644.00 10/09/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629178177
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,644.00 10/09/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629178805
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,644.00 10/09/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629180223
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $646.44 09/06/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629160965
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,500.00 09/06/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629164083
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $7,781.28 09/06/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629168891
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $250.00 09/06/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629173655
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $50.00 09/06/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629177689
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $50.00 08/27/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629164389
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $750.00 08/27/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629167573
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $750.00 08/27/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629174907
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $103.83 08/27/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629178499
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $750.00 08/22/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629165595
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $206.63 08/22/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629170423
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $100.00 08/22/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629179099
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,376.18 08/22/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629179959
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,256.00 08/19/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629161595
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,256.00 08/19/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629171393
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,644.00 08/19/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629171863
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,256.00 08/19/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629178339
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,256.00 08/19/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629179245
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $522.00 08/19/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629179537
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $915.90 07/12/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629169409
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,644.00 07/11/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629175305
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,256.00 07/11/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629177853
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,256.00 06/12/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629165297
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,256.00 06/12/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629169151
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,256.00 06/12/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629169921
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,256.00 06/12/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629172997
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,256.00 06/12/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629180091
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,256.00 05/22/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629160651
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,256.00 05/22/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629164995
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,644.00 05/17/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629171155
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,193.84 05/07/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629167839
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $185.99 05/03/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629171631
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $0.18 05/03/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629175695
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $250.00 05/03/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629177009
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $270.13 05/03/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629178953
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,256.00 04/23/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629161909
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,644.00 04/23/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629162533
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,644.00 04/23/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629166181
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,256.00 04/23/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629173219
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,256.00 04/23/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629179825
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,256.00 04/17/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629167023
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,099.08 03/06/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629167301
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,250.00 03/06/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629168367
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $640.29 03/06/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629174293
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $509.55 03/06/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629174501
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $889.10 03/06/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629175107
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $394.56 03/06/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629176459
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,000.00 03/06/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629177357
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $3,150.00 03/06/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629178015
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,044.90 03/06/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629178653
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,256.00 02/11/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629160333
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,256.00 02/11/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629163155
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,396.00 02/11/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629168103
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,256.00 02/11/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629170175
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,256.00 02/11/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629170913
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,256.00 02/11/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629172093
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,256.00 02/11/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629172325
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,644.00 02/11/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629177523
Principal investigator 1 AstraZeneca Pharmaceuticals LP $3,687.64 02/07/2019 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients with Chronic Kidney Disease No dispute reported 06/30/2026 685003599
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,000.00 01/31/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629163465
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $5,438.64 01/31/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629164693
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,250.00 01/31/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629165889
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $500.00 01/31/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629166465
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,250.00 01/31/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629169665
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $900.98 01/31/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629172553
Principal investigator 1 AstraZeneca Pharmaceuticals LP $12,006.68 01/24/2019 Non-covered Recipient Entity
Vanderbilt University Medical Center
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients with Chronic Kidney Disease No dispute reported 06/30/2026 684996073
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,491.00 01/07/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629166747
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,491.00 01/07/2019 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629173439